Your browser doesn't support javascript.
loading
Real-world outcomes of radium-223 dichloride for metastatic castration resistant prostate cancer.
Kuppen, Malou Cp; Westgeest, Hans M; van der Doelen, Maarten J; van den Eertwegh, Alphonsus Jm; Coenen, Jules Llm; Aben, Katja Kh; van den Bergh, Alphons Cm; Bergman, Andries M; den Bosch, Joan van; Celik, Filiz; Hendriks, Mathijs P; Lavalaye, Jules; der Meer, Saskia van; Polee, Marco B; Somford, Diederik M; van Oort, Inge M; Uyl-de Groot, Carin A; Gerritsen, Winald R.
Afiliación
  • Kuppen MC; Institute for Medical Technology Assessment, Erasmus School of Health Policy & Management, Erasmus University Rotterdam, Rotterdam, The Netherlands.
  • Westgeest HM; Department of Internal Medicine, Amphia Hospital, Breda, The Netherlands.
  • van der Doelen MJ; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands.
  • van den Eertwegh AJ; Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit, Amsterdam, the Netherlands.
  • Coenen JL; Department of Oncology, Isala, Zwolle, The Netherlands.
  • Aben KK; Department for Health Evidence, Radboud University Medical Center, Nijmegen, The Netherlands.
  • van den Bergh AC; Netherlands Comprehensive Cancer Organisation, Utrecht, The Netherlands.
  • Bergman AM; Department of Radiation Oncology, University Medical Center Groningen, Groningen, The Netherlands.
  • den Bosch JV; Division of Internal Medicine (MOD) & Oncogenomics, the Netherlands Cancer Institute Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
  • Celik F; Department of Internal Medicine, Albert Schweitzer Ziekenhuis, Dordrecht, The Netherlands.
  • Hendriks MP; Department of Nuclear Medicine, Deventer Hospital, Deventer, The Netherlands.
  • Lavalaye J; Department of Internal Medicine, Northwest Clinics, Alkmaar, The Netherlands.
  • der Meer SV; Department of Nuclear Medicine, St Antonius Hospital, Nieuwegein, The Netherlands.
  • Polee MB; Department of Urology, Jeroen Bosch Hospital, 's-Hertogenbosch, The Netherlands.
  • Somford DM; Department of Internal Medicine, Medical Center Leeuwarden, Leeuwarden, The Netherlands.
  • van Oort IM; Department of Urology, Canisius Wilhelmina Hospital, Nijmegen, The Netherlands.
  • Uyl-de Groot CA; Department of Urology, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Gerritsen WR; Institute for Medical Technology Assessment, Erasmus School of Health Policy & Management, Erasmus University Rotterdam, Rotterdam, The Netherlands.
Future Oncol ; 16(19): 1371-1384, 2020 Jul.
Article en En | MEDLINE | ID: mdl-32469606
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Radio (Elemento) / Neoplasias de la Próstata Resistentes a la Castración Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Aged80 / Humans / Male / Middle aged Idioma: En Revista: Future Oncol Año: 2020 Tipo del documento: Article País de afiliación: Países Bajos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Radio (Elemento) / Neoplasias de la Próstata Resistentes a la Castración Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Aged80 / Humans / Male / Middle aged Idioma: En Revista: Future Oncol Año: 2020 Tipo del documento: Article País de afiliación: Países Bajos